BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15/03/2011

FDA Clears ROCEPHIN Ceftriaxone Sodium Injection for Sale

The FDA has determined that ROCEPHIN ceftriaxone sodium injection, approved under NDA 050585, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

Source: Federal Register — Health and Human ServicesOpen original release →